Enterprise capital deal volumes within the European life sciences sector reached a record-breaking stage in 2021. Nonetheless, financing volumes decreased considerably by 29% within the first 4 months of...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Life Sciences Enterprise Capital Monitor – Europe 04/2022”. The Monitor is a month-to-month printed overview of enterprise...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 05/2022”. The Monitor is a month-to-month printed overview of enterprise...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Biotech Enterprise Capital Monitor – USA 05/2022”. The Monitor is a month-to-month printed overview of enterprise...
Through the first six months of 2022, we discover that the funding for all times sciences markets declined considerably in comparison with 2021. The pattern impacts all related life...
Throughout the first six months of 2022, we discover that the funding for all times sciences markets declined considerably in comparison with 2021. The pattern impacts all related life...
With 44 offers, the company enterprise arm of Boehringer Ingelheim was probably the most lively company investor within the European life science market within the final 5 years. The...
FCF Fox Company Finance GmbH is happy to publish the brand new “FCF AUTOMOTIVE SUPPLIER MARKET STUDY – 04/2022”. Based mostly on obtainable knowledge from European automotive suppliers, the...
FCF Fox Company Finance GmbH is happy to publish the brand new “FCF Curiosity & Company Mortgage Monitor Might 2022”. FCF commonly conducts complete analysis relating to the German...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Life Sciences Enterprise Capital Monitor – Europe 05/2022”. The Monitor is a month-to-month printed overview of enterprise...